Platelets in sickle cell disease: biomarkers, mediators, and lessons from clinical trials
Joanne C. Alfred, Erica M. Sparkenbaugh · 2026
Read Platelets in sickle cell disease: biomarkers, mediators, and lessons from clinical trials by Joanne C. Alfred, Erica M. Sparkenbaugh (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13675878.txt.
Description
Joanne Alfred and Erica Sparkenbaugh review, in 2026, the role of platelets in sickle cell disease. The disease is the most common inherited blood disorder in the world. A gene change makes red cells stiff and fragile, and the vessel walls stay irritated and sticky.
Platelets help drive the swelling and clotting that burden patients, the authors explain. The review covers how platelet measures can serve as markers of disease state. It also walks through what past drug trials teach about platelet roles in pain crises, stroke, and chest problems. Readers come away with a clear account of why these small cell fragments matter far beyond simple clotting.
Catalog record
| CREATOR | Joanne C. Alfred, Erica M. Sparkenbaugh |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 42 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |